1

SKIN-TO-TUMOR DISTANCE PREDICTS TREATMENT FAILURE OF
guidelines support the use of ablation modalities in patients with T1a (<4cm) disease, those at increased risk of multiple tumors (i.e. Von Hippel-Lindau syndrome), solitary kidney, or in patients with significant comorbidities who are poor surgical candidates 6, 7 . However, while durable disease response is favorable in patients who have undergone PCA, reported local treatment failure rates remain relatively high, from 5-30% in comparison to less than 2% following partial nephrectomy 8 ,9,10 .
Tumor and patient characteristics such as tumor size, location, depth, and patient body mass index (BMI) account for the complexity of a procedure and potentially lead to higher treatment failure and complication rates [11] [12] [13] . Current reports support the assertion that PCA should only be applied to T1a (<4cm) renal cell carcinoma variants, with early evidence corroborating that tumor size directly affects oncologic outcomes 14 . Further, the location of the tumor such as anterior or upper pole lesions, may have significant impact on the difficulty of needle deployment and proper lesion targeting 12, 15 . In addition, proximity of the tumor to hilar vessels, has also been hypothesized to contribute to treatment failure due to the possibility of "heat sink", or the inability for the juxtavascular probe to reach temperatures low enough to induce complete tumor necrosis 11, 12, 14 . Treatment algorithms that take into account the size, location, and proximity to surrounding retroperitoneal and abdominal structures have been developed that are predictive of treatment difficulty and complications, however, few studies combining patient and tumor specific variables to predict long-term procedural outcomes have been conducted 16 . Pareek and colleagues first introduced the concept of skin-to-target (stone) distance as a predictor of outcomes for stone disease in the setting of shockwave lithotripsy 17 . Subsequently, Blute and colleagues described skin-totumor (STT) distance for renal cortical neoplasms in a heterogeneous population of patients with benign, malignant, and indeterminant tumors of all sizes 13 . Herein we evaluated skin-totumor distance as a predictor of treatment failure following percutaneous cryoablation in Page 3 of 18 4 patients with biopsy proven T1a RCC. It is our hypothesis that tumors deeper in the body may be harder to eradicate with contemporary cryoablation.
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METHODS:
Study Design
After Institutional Review Board approval, we conducted a retrospective chart review of all patients with biopsy proven T1a RCC who underwent primary treatment with PCA at two academic institutions between December 2005 and June 2015. Only patients with available preoperative imaging were included in this analysis. We collected and analyzed patient demographics, peri-and post-operative characteristics to determine preoperative factors predictive of treatment failure following primary PCA.
Measurements
Preoperative computed tomography (CT) and magnetic resonance imaging (MRI) scans were used to determine STT distances for all patients according to the methods of Pareek and colleagues (2005) . The average of the three measurements at 0 degrees posteriorly, 45, and 90 degrees laterally from the skin to the center of the tumor were recorded as the STT 17 ( Figure 1 ). Probe distance was taken as the average distance from surface of the skin to tip of the probe for each probe based on inter-procedural CT images.
Tumor size (i.e. largest axial diameter), tumor polarity, and tumor depth were recorded. With regard to polarity, tumors that crossed the midline between the upper and lower poles were classified as interpolar. Tumors protruding more than 50% from the renal parenchyma were categorized as exophytic, while those that were protruding less than or equal to 50% were deemed mesophytic. Tumors entirely confined within the renal parenchyma were categorized as endophytic. A R.E.N.A.L. Nephrometry score was determined for each tumor based on the method of Kutikov and colleagues 18 .
Surgical Technique
At both institutions, all PCA were performed in a hospital-based interventional radiology suite as a combined effort between interventional radiologist and urologist. The PCA technique used at both institutions involved a double freeze thaw cycle as previously described 17, 21 . The total number of probes placed was based on the tumor size. 
Statistical analysis
The Table 2 and Supplementary Table 2 ).
Ten complications (12%) were noted (Supplementary table 3 Current guidelines recommend surgical extirpation for all renal cortical masses despite the finding that upwards of 30% of these lesions are benign or of low malignant potential 19 . Over the past decade, PCA has emerged as an effective, less morbid, alternative treatment modality. PCA preserves renal parenchyma and minimizes morbidity, convalescence time, and costs versus surgical excision 20, 21 . Moreover, PCA offers similar cancer specific and metastasis free survival to the gold standard, partial nephrectomy 9 . Still, reported local treatment failure after PCA is higher than with surgical extirpation indicating that better patient selection or improved ablation techniques are needed. To this end, we compared patient and tumor characteristics relevant to PCA procedural planning and complexity in patients with documented T1a disease.
Previous PN studies have demonstrated that tumor specific variables such as size, depth within the kidney, and tumor polarity and location relative to the renal hilum significantly impact outcomes including perioperative complications and oncological outcomes 11, 12, 22 .
However, this does not seem to be the case for PCA. Indeed, in our study of pathological T1a renal cancers treatment failure rates following PCA were not dependent on the aforedescribed tumor specific variables. This is consistent with previous findings that PCA, may be used to successfully treat even anteriorly located tumors independent of tumor size and proximity to the renal hilum 11, [23] [24] [25] . It is important to note that the selection criteria of the current manuscript include only T1a RCC variants, which are, by definition, all ≤4cm. As such, we continue to prefer to limit cryoablation to tumors that are 3 cm or smaller. While the relevance of tumor size and location for SRM remains concerning, the use of multiple probes, facile use of intra-operative monitoring of ablative margins, and surgeon's experience appear to contribute to successful ablation.
The R.E.N.A.L. Nephrometry score is a proven metric of complexity that has utility for surgical planning and has been demonstrated to be predictive of outcomes following either PN or PCA 26, 27 . In a study of 751 mixed renal tumors, Schmit and colleagues found that a R.E.N.A.L. Nephrometry score greater than 8 correlated with risk of early and overall treatment failure following both PCA and radiofrequency ablation (RFA) 24 . Camacho and colleagues similarly found that the R.E.N.A.L. Nephrometry score was significantly associated with treatment failure following PCA and RFA 22 . In contrast, in the present study, Page 9 of 18 tumor complexity, as indicated by the R.E.N.A.L. Nephrometry score, was not a significant predictor of treatment failure after PCA. One reason for this discrepancy could be that in both studies evaluated PCA and RFA together; as such, the Nephrometry score may indeed be less predictive for PCA when considered alone. Also it is also possible that our negative Nephrometery results are secondary to a pretreatment selection bias. In general, tumors chosen for PCA in the current series were small (i.e. all T1a) and of low to moderate complexity, hence we may have had too few patients with a higher Nephrometry score to allow for a more balanced analysis.
It is clear that an important variable that contributes to complexity of the PCA procedure is In agreement with the earlier study by Blute and colleagues, we noted that increased skin-to-tumor distance predicts subsequent treatment failure. Indeed, with every centimeter of increased STT, the risk of treatment failure rose by 32%. Moreover, in patients with STT greater than 10 cm, risk of treatment failure was increased four fold versus those with a STT less than 10 cm. These findings are consistent with recent observations by Prince and colleagues, which demonstrate that greater STT is associated with higher failure rates of percutaneous renal biopsy 28 . Taken together, it is likely that greater STT complicates effective targeting of renal lesions be it for biopsy or for PCA.
It is also possible that increased tumor depth within the body may result in a heat sink phenomenon along the cryoablation probe itself. Previous observations have revealed that the use of multi-point temperature sensing needles allows for precise measurement of the lethal freeze temperature within the target lesion. With the insurance that lethal temperatures have been reached, treatment failure rates may be all but eliminated 29 . Unfortunately, it is not standard of practice to employ multi-point temperature sensing needles, and relative freeze temperatures cannot be confirmed within the current cohort. Finally, in the current study, younger age at the time of surgery was a predictor of treatment failure. Older age has previously been implicated as a worse prognostic indicator in patients with T1a disease 32 . Paradoxically, consistent with our findings, a recent epidemiological study showed a survival benefit in patients between the ages of 50-59 undergoing partial nephrectomy compared to tumor ablation 33 . Further exploration of the relationships between age, tumor type, and ablative outcomes is very much needed.
Limitations of our study are most certainly related to its retrospective design. Also, the relatively small number of treatment failures limits the statistical power of the analysis and may introduce bias into our findings. Certainly the creation of a national tumor registry that would separate percutaneous ablation between cryoablation and radiofrequency ablation is Page 11 of 18 needed as, currently, in SEER data bases as well as other data bases, the two are lumped together. Finally, a larger, prospective analysis is recommended to further test the findings in the present study.
CONCLUSIONS:
STT is an easily measured preoperative variable that is linearly associated with increased risk of RCC treatment failure following PCA of T1a tumors. An STT of > 10 cm is predictive of a 4 fold higher rate of treatment failure.
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